Clinigen Group PLC (LON:CLIN)‘s stock had its “buy” rating reaffirmed by equities research analysts at Peel Hunt in a report issued on Thursday. They presently have a GBX 1,000 ($14.64) price objective on the stock. Peel Hunt’s price objective indicates a potential upside of 81.82% from the company’s current price. A number of other equities […]
